Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples